Teladoc Health Inc (TDOC) VP Mark Hirschhorn Sells 10,000 Shares

Teladoc Health Inc (NYSE:TDOC) VP Mark Hirschhorn sold 10,000 shares of the company’s stock in a transaction that occurred on Friday, November 2nd. The stock was sold at an average price of $70.13, for a total transaction of $701,300.00. Following the transaction, the vice president now owns 12,284 shares of the company’s stock, valued at $861,476.92. The transaction was disclosed in a filing with the SEC, which is available through this link.

Mark Hirschhorn also recently made the following trade(s):

  • On Tuesday, September 25th, Mark Hirschhorn sold 35,000 shares of Teladoc Health stock. The stock was sold at an average price of $80.42, for a total transaction of $2,814,700.00.

Shares of NYSE TDOC opened at $72.51 on Friday. Teladoc Health Inc has a 52-week low of $27.30 and a 52-week high of $89.05. The company has a quick ratio of 3.14, a current ratio of 3.14 and a debt-to-equity ratio of 0.58. The company has a market capitalization of $5.04 billion, a price-to-earnings ratio of -43.95 and a beta of 0.96.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings data on Thursday, November 1st. The health services provider reported ($0.34) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.36) by $0.02. Teladoc Health had a negative net margin of 31.32% and a negative return on equity of 16.52%. The company had revenue of $111.00 million during the quarter, compared to analysts’ expectations of $109.94 million. During the same period in the prior year, the company posted ($0.55) earnings per share. Teladoc Health’s revenue for the quarter was up 61.6% compared to the same quarter last year. As a group, research analysts expect that Teladoc Health Inc will post -1.49 earnings per share for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the company. Harvest Fund Management Co. Ltd acquired a new stake in shares of Teladoc Health during the third quarter worth $165,000. Garner Asset Management Corp acquired a new stake in shares of Teladoc Health during the second quarter worth $200,000. Pier 88 Investment Partners LLC acquired a new stake in shares of Teladoc Health during the second quarter worth $201,000. Aperio Group LLC acquired a new stake in shares of Teladoc Health during the second quarter worth $201,000. Finally, California Public Employees Retirement System acquired a new stake in shares of Teladoc Health during the second quarter worth $203,000.

Several equities analysts have issued reports on the stock. Oppenheimer upped their price target on shares of Teladoc Health from $59.00 to $68.00 and gave the company an “outperform” rating in a research report on Thursday, August 2nd. MED upped their price target on shares of Teladoc Health from $68.00 to $89.00 and gave the company an “outperform” rating in a research report on Friday, September 28th. KeyCorp upped their price target on shares of Teladoc Health from $70.00 to $74.00 and gave the company an “overweight” rating in a research report on Thursday, August 2nd. Wells Fargo & Co restated a “buy” rating and issued a $70.00 price target on shares of Teladoc Health in a research report on Thursday, August 2nd. Finally, Canaccord Genuity restated a “buy” rating and issued a $70.00 price target on shares of Teladoc Health in a research report on Thursday, August 2nd. One analyst has rated the stock with a sell rating, four have given a hold rating, fifteen have issued a buy rating and one has assigned a strong buy rating to the company. The stock presently has a consensus rating of “Buy” and a consensus target price of $82.95.

Teladoc Health Company Profile

Teladoc Health, Inc provides telehealth services worldwide. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Featured Story: Dow Jones Industrial Average (DJIA)

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply